AnaptysBio

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AnaptysBio and other ETFs, options, and stocks.

About ANAB

AnaptysBio, Inc. is a clinical stage biotechnology company. engages in the development of antibody product candidates. Its products pipeline include ANB030, ANB030, and Imsidolimab. 

CEO
Daniel R. Faga
CEODaniel R. Faga
Employees
136
Employees136
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
2005
Founded2005
Employees
136
Employees136

ANAB Key Statistics

Market cap
1.05B
Market cap1.05B
Price-Earnings ratio
-12.77
Price-Earnings ratio-12.77
Dividend yield
Dividend yield
Average volume
352.07K
Average volume352.07K
High today
$39.50
High today$39.50
Low today
$35.91
Low today$35.91
Open price
$36.00
Open price$36.00
Volume
128.82K
Volume128.82K
52 Week high
$39.78
52 Week high$39.78
52 Week low
$12.21
52 Week low$12.21

Stock Snapshot

As of today, AnaptysBio(ANAB) shares are valued at $37.75. The company's market cap stands at 1.05B, with a P/E ratio of -12.77.

As of 2025-11-06, AnaptysBio(ANAB) stock has fluctuated between $35.91 and $39.50. The current price stands at $37.75, placing the stock +5.1% above today's low and -4.4% off the high.

The AnaptysBio(ANAB)'s current trading volume is 128.82K, compared to an average daily volume of 352.07K.

During the past year, AnaptysBio(ANAB) stock moved between $12.21 at its lowest and $39.78 at its peak.

During the past year, AnaptysBio(ANAB) stock moved between $12.21 at its lowest and $39.78 at its peak.

ANAB News

TipRanks 1d
AnaptysBio’s Strategic Split and Robust Pipeline Justify Buy Rating

H.C. Wainwright analyst Emily Bodnar maintained a Buy rating on AnaptysBio today and set a price target of $59.00. Elevate Your Investing Strategy: Take advanta...

TipRanks 1d
AnaptysBio Reports Q3 2025 Results and Strategic Plans

AnaptysBio ( (ANAB) ) has released its Q3 earnings. Here is a breakdown of the information AnaptysBio presented to its investors. Elevate Your Investing Strateg...

Analyst ratings

92%

of 12 ratings
Buy
91.7%
Hold
8.3%
Sell
0%

People also own

Based on the portfolios of people who own ANAB. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.